Mindray Medical International Limited (NYSE:MR)
| CAPS Rating |
|
|---|
MR
VS S&P 500 (SPY)
MR News and Commentary
- Mindray's Mixed Results - Analyst Blog – NASDAQ
- ADR Report: Shares Fall On Renewed Euro-Zone Worries – SmartMoney
- Mindray Medical International Limited Meets on the Top Line, Misses Where It Counts – The Motley Fool
- Why Mindray Medical Sank Then Rebounded – The Motley Fool
- HealthTrust Selects Mindray - Analyst Blog – NASDAQ
- Mindray to Attend Medical Fair - Analyst Blog – NASDAQ
- Something to Watch at Mindray Medical International – The Motley Fool
- 12 Healthcare Dividend Stocks With Gaining Earnings Momentum – Trefis
- Reaffirming Mindray at Neutral - Analyst Blog – NASDAQ
How do you think MR will perform against the market?
Motley Fool CAPS is a community working together to find better stocks and to become better investors.
Powered by: CAPSAll Players
1,368
Outperform
36
Underperform
All-Star Players
279
Outperform
13
Underperform
Wall Street
7
Outperform
1
Underperform
RSS Headlines
Fool UK
